Upstream Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-13 08:35:27 ET UPB

Published on 05/13/2026 at 08:35 am EDT

Upstream Bio, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 1.03 million compared to USD 0.566 million a year ago. Net loss was USD 40.59 million compared to USD 27.27 million a year ago.

Basic loss per share from continuing operations was USD 0.75 compared to USD 0.51 a year ago. Diluted loss per share from continuing operations was USD 0.75 compared to USD 0.51 a year ago.